(2R,4S)-2-[(R)-benzylcarbamoyl-phenylacetyl-methyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid

This compound is a synthetic small molecule belonging to the class of N-acyl-alpha amino acids and derivatives. It is also known as benzylpenicilloyl-benzylamine or BPO–BA. The structure features a thiazolidine ring with dimethyl substitution and complex acyclic side chains containing benzamide and phenoxy moieties. There are no approved medical indications or clinical trials for this compound; it is classified as experimental[1][2]. Its mechanism of action has not been described in the literature and there are no data on its pharmacological activity or therapeutic use.

Other names

benzylpenicilloyl-benzylamine(2R,4S)-2-{(1R)-2-(Benzylamino)-2-oxo-1-[(phenylacetyl)amino]ethyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid4-Thiazolidinecarboxylic acid, 5,5-dimethyl-2-[ (1R ) -2 -oxo -1-[ ( 2 -phenylacetyl ) amino ] -2-[ ( phenylmethyl ) amino ] ethyl ]-, ( 2 R , 4 S )